1
Research Article
Vol. 2, Issue 1
RECURRENT RECTAL ADENOCARCINOMA WITH KRAS MUTATION POST-MFOLFOX6/BEVACIZUMAB REMISSION: A CASE REPORT
Background: This case report elucidates the clinical trajectory of a 41-year-old male diagnosed with low rectal adenocarcinoma, further complicated by pulmonary metastases, harboring a KRAS mutation, and characterized by microsatellite stability. Case Presentation: This patient demonstrated a significant and favorable response to neoadjuvant chemot...